Cuprina Holdings (Cayman) (CUPR) Non-Current Debt (2023 - 2025)

Cuprina Holdings (Cayman)'s (CUPR) quarterly Non-Current Debt came in at $110509.9 in Q2 2025, down 10.22% on a QoQ basis from $123086.9 in Q4 2024.

Cuprina Holdings (Cayman) (CUPR) Non-Current Debt (2023 - 2025) Analysis & Trends

Cuprina Holdings (Cayman) (CUPR) has 3 years of Non-Current Debt data on file, last reported at $110509.9 in Q2 2025.

Quarterly Non-Current Debt changed N/A year-over-year to $110509.9 in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $110509.9 (changed N/A YoY) and the FY2024 annual result came in at $122568.3, up 662.57% from the prior year.
Non-Current Debt declined to $110509.9 in Q2 2025, from $123086.9 in the prior quarter.
In the past five years, Non-Current Debt ranged from a high of $123086.9 in Q4 2024 to a low of $16073.0 in Q4 2023.
A 3-year average of $83223.3 and a median of $110509.9 in 2025 frame the typical range for Non-Current Debt.
The widest YoY moves for Non-Current Debt: up 665.8% in 2024, down 665.8% in 2024.
Tracing CUPR's Non-Current Debt over 3 years: stood at $16073.0 in 2023, then surged by 665.8% to $123086.9 in 2024, then dropped by 10.22% to $110509.9 in 2025.
The last three Non-Current Debt figures came in at $110509.9 (Q2 2025), $123086.9 (Q4 2024), and $16073.0 (Q4 2023), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Non-Current Debt (Qtr)
1	Intuitive Surgical	134.22 Bn	129.00 Bn	1.96 Bn	-
2	Becton Dickinson	52.42 Bn	51.56 Bn	2.32 Bn	13.51 Bn
3	Alcon	35.74 Bn	34.39 Bn	1.68 Bn	4.15 Bn
4	Resmed	33.89 Bn	32.42 Bn	861.22 Mn	399.42 Mn
5	Medline	28.89 Bn	26.21 Bn	2.22 Bn	12.55 Bn
6	West Pharmaceutical Services	25.07 Bn	24.64 Bn	329.20 Mn	202.90 Mn
7	Solventum	15.30 Bn	14.90 Bn	1.29 Bn	4.57 Bn
8	Cooper Companies	14.83 Bn	14.69 Bn	735.40 Mn	1.86 Bn
9	Baxter International	13.62 Bn	11.47 Bn	1.03 Bn	8.62 Bn
10	Cuprina Holdings (Cayman)	7.28 Mn	7.28 Mn	-	-

Download Data